Stryker Corporation (SYK) Plans $0.47 Quarterly Dividend

Stryker Corporation (NYSE:SYK) declared a quarterly dividend on Wednesday, February 7th, Zacks reports. Investors of record on Thursday, March 29th will be given a dividend of 0.47 per share by the medical technology company on Monday, April 30th. This represents a $1.88 annualized dividend and a yield of 1.24%. The ex-dividend date is Wednesday, March 28th.

Stryker has increased its dividend payment by an average of 11.7% per year over the last three years and has increased its dividend every year for the last 7 years. Stryker has a payout ratio of 29.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Stryker to earn $7.82 per share next year, which means the company should continue to be able to cover its $1.88 annual dividend with an expected future payout ratio of 24.0%.

Stryker (SYK) traded down $2.15 during mid-day trading on Thursday, reaching $151.52. 333,291 shares of the company traded hands, compared to its average volume of 1,430,671. The firm has a market capitalization of $56,800.00, a price-to-earnings ratio of 56.63, a price-to-earnings-growth ratio of 2.22 and a beta of 0.70. The company has a current ratio of 2.29, a quick ratio of 1.59 and a debt-to-equity ratio of 0.66. Stryker has a 1-year low of $122.28 and a 1-year high of $170.00.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.01. The business had revenue of $3.47 billion for the quarter, compared to analyst estimates of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.55%. Stryker’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 earnings per share. equities analysts anticipate that Stryker will post 7.12 earnings per share for the current year.

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. upgraded shares of Stryker from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 2nd. Robert W. Baird upgraded shares of Stryker from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $161.00 to $173.00 in a report on Thursday, November 16th. BMO Capital Markets upgraded shares of Stryker to a “market perform” rating and set a $163.00 price objective on the stock in a report on Tuesday, December 12th. Zacks Investment Research lowered shares of Stryker from a “hold” rating to a “sell” rating in a report on Monday, October 16th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $163.00 price objective on shares of Stryker in a report on Friday, January 5th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $162.50.

In other news, insider Graham A. Mclean sold 2,984 shares of the business’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $160.53, for a total transaction of $479,021.52. Following the completion of the sale, the insider now directly owns 9,100 shares of the company’s stock, valued at $1,460,823. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Howard E. Cox, Jr. sold 7,400 shares of the company’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $164.09, for a total transaction of $1,214,266.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 16,840 shares of company stock valued at $2,749,989. 7.40% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Plans $0.47 Quarterly Dividend” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Dividend History for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with's FREE daily email newsletter.

Leave a Reply